2004 Competition Prescription 
PM360
JUNE 29, 2022
However, patient uptake hasn’t matched rising market competition. Among surveyed patients, nearly half (47%) couldn’t remember a single preventive migraine brand name, and the leading brand patients did recall— Topamax —is an older drug that was approved for migraine in 2004.
European Pharmaceutical Review
JULY 4, 2024
1 For use as prescription drugs, a botanical product must be approved by the FDA: to date, only two have gained this approval. 10 Directive 2004/24/EC introduced a registration scheme for traditional herbal medicines and requires herbal remedies sold over the counter in the UK to be registered. 2012/1916). 2012/1916).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
AUGUST 22, 2022
1 This has led to a great deal of pre-competitive data sharing. As the data is anonymised it will not be possible to select excipient suppliers based on lowest available nitrite levels, but it may prompt some suppliers to publish this information as it could provide a competitive advantage. 2022 [cited 30 July 2022]. Assessment report.
Cadensee
JULY 20, 2021
When he was going through his cancer, he died in 2004. But in terms of Israel as a competitive advantage, I think data is much more than just good technology. But let's say I plug in Medisafe to my EHR and click, all my medication, all my prescriptions with the doctor's orders are then logged on automatically.
Pharmaceutical Technology
JANUARY 6, 2023
In 2020, the Federal Trade Commission issued a report regarding settlements reached between brand and generic manufacturers in FY 2017 and noted that “for the first time since [FY] 2004, no settlement agreement in [FY] 2017 contains a no-[authorized generic] AG commitment.”. Throughout 2022, Novartis was at the opposing ends of legal cases.
Expert insights. Personalized for you.
98 
Let's personalize your content